# Irinotecan hydrochloride

NDC: 16714-027
Generic name: Irinotecan hydrochloride
Labeler / Manufacturer: Northstar Rx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20201115

FDA application: ANDA212993

## Active ingredients

- IRINOTECAN HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16714-027"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16714-027
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f98e9ed-f7b1-5346-af72-fccb0abf3f4b